loading

Werewolf Therapeutics Inc (HOWL) 最新ニュース

pulisher
02:33 AM

Werewolf Therapeutics Inc. stock trend forecastWall Street Watch & Accurate Entry/Exit Alerts - newser.com

02:33 AM
pulisher
Nov 08, 2025

FY2025 Earnings Estimate for HOWL Issued By Leerink Partnrs - Defense World

Nov 08, 2025
pulisher
Nov 08, 2025

Wedbush Expects Increased Earnings for Werewolf Therapeutics - Defense World

Nov 08, 2025
pulisher
Nov 07, 2025

Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for ... - Bluefield Daily Telegraph

Nov 07, 2025
pulisher
Nov 07, 2025

Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting - Stock Titan

Nov 07, 2025
pulisher
Nov 07, 2025

Mpm Bioventures sells Werewolf Therapeutics (HOWL) stock for $295k By Investing.com - Investing.com South Africa

Nov 07, 2025
pulisher
Nov 06, 2025

Werewolf Therapeutics: Multiple 10% owners sell $295k in shares By Investing.com - Investing.com Philippines

Nov 06, 2025
pulisher
Nov 06, 2025

Mpm Bioventures sells Werewolf Therapeutics (HOWL) stock for $295k - Investing.com India

Nov 06, 2025
pulisher
Nov 06, 2025

Werewolf Therapeutics: Multiple 10% owners sell $295k in shares - Investing.com India

Nov 06, 2025
pulisher
Nov 06, 2025

Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $189,830 - Investing.com India

Nov 06, 2025
pulisher
Nov 06, 2025

Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $189,830 By Investing.com - Investing.com Canada

Nov 06, 2025
pulisher
Nov 06, 2025

[Form 4] Werewolf Therapeutics, Inc. Insider Trading Activity - Stock Titan

Nov 06, 2025
pulisher
Nov 06, 2025

Werewolf Therapeutics Faces Nasdaq Compliance Challenge - MSN

Nov 06, 2025
pulisher
Nov 06, 2025

How Werewolf Therapeutics Inc. stock performs after earningsJuly 2025 WrapUp & Verified Chart Pattern Signals - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Visual trend scoring systems applied to Werewolf Therapeutics Inc.July 2025 PostEarnings & Safe Entry Trade Reports - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Is Werewolf Therapeutics Inc. stock bottoming out2025 Biggest Moves & Safe Swing Trade Setups - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Predicting Werewolf Therapeutics Inc. trend using moving averagesQuarterly Trade Report & Technical Entry and Exit Tips - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Will Werewolf Therapeutics Inc. price bounce be sustainableMarket Performance Recap & Community Consensus Stock Picks - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Will Werewolf Therapeutics Inc. stock outperform growth indexes2025 Earnings Impact & AI Enhanced Trading Signals - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

How to read the order book for Werewolf Therapeutics Inc.Analyst Upgrade & Technical Pattern Based Signals - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Analyzing recovery setups for Werewolf Therapeutics Inc. investors2025 Price Action Summary & Safe Entry Zone Tips - newser.com

Nov 06, 2025
pulisher
Nov 05, 2025

Advanced analytics toolkit walkthrough for Werewolf Therapeutics Inc.Weekly Investment Report & AI Based Buy and Sell Signals - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Will Werewolf Therapeutics Inc. stock recover faster than market2025 Market Outlook & Risk Managed Investment Signals - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Wedbush Halves Price Target on Werewolf Therapeutics to $3 From $6, Keeps Outperform Rating - MarketScreener

Nov 05, 2025
pulisher
Nov 05, 2025

Werewolf Therapeutics Narrows Losses And Wins FDA Fast Track Nod - Finimize

Nov 05, 2025
pulisher
Nov 05, 2025

Why Werewolf Therapeutics Inc. stock is rated strong buyTake Profit & Safe Capital Growth Stock Tips - fcp.pa.gov.br

Nov 05, 2025
pulisher
Nov 05, 2025

Identifying reversal signals in Werewolf Therapeutics Inc.July 2025 Momentum & Consistent Profit Alerts - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

What MACD signals say about Werewolf Therapeutics Inc.2025 Price Action Summary & Low Risk Entry Point Tips - newser.com

Nov 05, 2025
pulisher
Nov 04, 2025

Werewolf Therapeutics Reports Q3 2025 Financial Results - TipRanks

Nov 04, 2025
pulisher
Nov 04, 2025

Luke Evnin Sells 55,795 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

Werewolf Therapeutics (NASDAQ:HOWL) Director Luke Evnin Sells 60,369 Shares - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

Bioventures 2014 L.P. Mpm Sells 86,936 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells 114,044 Shares of Stock - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

Ansbert Gadicke Sells 86,936 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Ansbert Gadicke Sells 114,044 Shares - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells 94,063 Shares of Stock - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells $121,341.27 in Stock - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

Werewolf Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Nov 04, 2025
pulisher
Nov 04, 2025

Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - Investing News Network

Nov 04, 2025
pulisher
Nov 04, 2025

Werewolf Therapeutics Q3 net loss narrows on lower R&D expenses - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

[8-K] Werewolf Therapeutics, Inc. Reports Material Event | HOWL SEC FilingForm 8-K - Stock Titan

Nov 04, 2025
pulisher
Nov 04, 2025

Werewolf Therapeutics (NASDAQ: HOWL) says cash funds operations into Q4 2026 - Stock Titan

Nov 04, 2025
pulisher
Nov 04, 2025

Is Werewolf Therapeutics Inc. reversing from oversold territory2025 Top Decliners & Proven Capital Preservation Methods - newser.com

Nov 04, 2025
pulisher
Nov 03, 2025

Werewolf therapeutics director Evnin sells $251k in HOWL stock - Investing.com India

Nov 03, 2025
pulisher
Nov 03, 2025

Werewolf therapeutics director Evnin sells $251k in HOWL stock By Investing.com - Investing.com Australia

Nov 03, 2025
$38.56
price down icon 5.44%
$28.66
price down icon 0.62%
$105.98
price up icon 0.70%
$103.14
price down icon 0.20%
biotechnology ONC
$319.97
price down icon 3.73%
$189.70
price up icon 2.17%
大文字化:     |  ボリューム (24 時間):